Ivosidenib for advanced IDH1-mutant cholangiocarcinoma

Abou-Alfa, GK; Pandya, SS; Zhu, AX

Zhu, AX (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA.; Zhu, AX (corresponding author), Jiahui Hlth, Jiahui Int Canc Ctr, Shanghai, Peoples R China.

LANCET ONCOLOGY, 2020; 21 (8): E371